Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Screening: Early alert.

× No keyword cloud information.

5 in total

1. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

Authors: Wendy S Atkin; Rob Edwards; Ines Kralj-Hans; Kate Wooldrage; Andrew R Hart; John M A Northover; D Max Parkin; Jane Wardle; Stephen W Duffy; Jack Cuzick
Journal: Lancet Date: 2010-04-27 Impact factor: 79.321

2. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings.

Authors: T F Imperiale; D R Wagner; C Y Lin; G N Larkin; J D Rogge; D F Ransohoff
Journal: N Engl J Med Date: 2000-07-20 Impact factor: 91.245

3. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

Authors: D A Lieberman; D G Weiss; J H Bond; D J Ahnen; H Garewal; G Chejfec
Journal: N Engl J Med Date: 2000-07-20 Impact factor: 91.245

4. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma.

Authors: Nicholas T Potter; Patrick Hurban; Mary N White; Kara D Whitlock; Catherine E Lofton-Day; Reimo Tetzner; Thomas Koenig; Neil B Quigley; Gunter Weiss
Journal: Clin Chem Date: 2014-06-17 Impact factor: 8.327

5. Multitarget stool DNA testing for colorectal-cancer screening.

Authors: Thomas F Imperiale; David F Ransohoff; Steven H Itzkowitz; Theodore R Levin; Philip Lavin; Graham P Lidgard; David A Ahlquist; Barry M Berger
Journal: N Engl J Med Date: 2014-03-19 Impact factor: 91.245

5 in total

7 in total

Review 1. GUCY2C ligand replacement to prevent colorectal cancer.

Authors: Erik S Blomain; Amanda M Pattison; Scott A Waldman
Journal: Cancer Biol Ther Date: 2016-04-22 Impact factor: 4.742

2. Complementary Glycomic Analyses of Sera Derived from Colorectal Cancer Patients by MALDI-TOF-MS and Microchip Electrophoresis.

Authors: Christa M Snyder; William R Alley; Margit I Campos; Martin Svoboda; John A Goetz; Jaqueline A Vasseur; Stephen C Jacobson; Milos V Novotny
Journal: Anal Chem Date: 2016-09-13 Impact factor: 6.986

Screening: Early alert.

1. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

2. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings.

3. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

4. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma.

5. Multitarget stool DNA testing for colorectal-cancer screening.

Review 1. GUCY2C ligand replacement to prevent colorectal cancer.

2. Complementary Glycomic Analyses of Sera Derived from Colorectal Cancer Patients by MALDI-TOF-MS and Microchip Electrophoresis.

3. Use of integrin alpha 6 transcripts in a stool mRNA assay for the detection of colorectal cancers at curable stages.

4. Droplet digital PCR for quantification of ITGA6 in a stool mRNA assay for the detection of colorectal cancers.

Review 5. Colorectal cancer: evolution of screening strategies.

Review 6. Integrin α6β4 in Colorectal Cancer: Expression, Regulation, Functional Alterations and Use as a Biomarker.

7. Multitarget Stool mRNA Test for Detecting Colorectal Cancer Lesions Including Advanced Adenomas.